The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens

Journal of General Internal Medicine

Volumn 20, Issue 7, 2005, Pages 653-656

  Glasheen, Jeffrey J ^a,c   Fugit, Randolph V ^b   Prochazka, Allan V ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO HOSPITAL   (United States)

Author keywords

Azithromycin; Drug interaction; Levofloxacin; Overanticoagulation; Trimethoprim sulfamethoxazole; Warfarin

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; AZITHROMYCIN; COTRIMOXAZOLE; LEVOFLOXACIN; TERAZOSIN; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; BLEEDING; COHORT ANALYSIS; EPIDIDYMITIS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; OTITIS; OUTPATIENT; PHARYNGITIS; RETROSPECTIVE STUDY; SINUSITIS; STATISTICAL SIGNIFICANCE; THROMBOSIS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; AGED; ANTI-INFECTIVE AGENTS; ANTICOAGULANTS; AZITHROMYCIN; COHORT STUDIES; DRUG INTERACTIONS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; OFLOXACIN; PLATELET AGGREGATION INHIBITORS; PRAZOSIN; RETROSPECTIVE STUDIES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; WARFARIN;

EID: 22644446905     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2005.0136.x     Document Type: Article

References (18)

1. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. Ann Intern Med. 2003;139:893-900.
2. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant therapy. Chest. 2001;119:1083-21.
3. Cannegueter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;333:11-7.
4. Glasheen JJ, Fugit RV. How warfarin interacts with common antibiotics. Emerg Med. 2004;36:30C-301.
5. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med. 1994;121:676-83.
6. Penning-van Beest FJ, Van Meegen E, Rosendaal FR, Stricker BH. Drug interactions as a cause of overanticoagulation on pheriprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther. 2001;69:451-7.
7. Panneerselvam S, Baglin C, Lefort W, Baglin T. Analysis of risk factors for over anticoagulation in patients receiving long-term warfarin. Br J Hematol. 1998;103:422-4.
8. Horton JD, Bushwick BM. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician. 1999;59:635-46.
9. Beckey NP, Parra D, Colon A. Retrospective evaluation of a potential interaction between azithromycin and warfarin in patients stabilized on warfarin. Pharmacotherapy. 2000;20:1055-9.
10. Tatro DS, ed. Drug Interaction Facts. St. Louis. Mo: Facts and Comparisons: 2003.
11. McCall KL, Anderson HG, Jones AD. Determination of the lack of a drug interaction between azithromycin and warfarin. Pharmacotherapy. 2004;24:188-94.
12. Rindone JP, Kuey CL, Jones WN, Garewal HS. Hypoprothrombinemic effect of warfarin not influenced by ciprofloxacin. Clin Pharm. 1991;10: 136-8.
13. Bianco TM, Bussey HI, Farnett LE, Linn WD, Roush MK, Wong YW. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation. Pharmacotherapy. 1992;12:435-9.
14. Israel DS, Stotka J, Rock W, et al. Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin. CID. 1996;22: 251-6.
15. Liao S, Palmer M, Fowler C, Nayak RK. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. J Clin Pharmacol. 1996;36:1072-7.
16. Yamreudeewong W, Lower DL, Kipatrick DM, Enlow AM, Burrows MM, Greenwood MC. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy. Pharmacotherapy. 2003;23:333-8.
17. Glasheen JJ, Fugit RV, Prochazka AV. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy-a comment. Pharmacotherapy. 2003;23:1079-80.
18. O'Reilly RA, Motley CH. Racemic warfarin and trimethoprim- sulfamethoxasole interaction in humans. Ann Intern Med. 1979;91: 34-6.